How Far Could We Go with Open Data – A Case Study for TRPV1 Antagonists
Version of Record online: 18 JUN 2013
© 2013 The Authors. Published by Wiley-VCH Verlag GmbH & Co KGaA. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Special Issue: 19th European Symposium on Quantitative Structure-Activity Relationships (EuroQSAR 2012 – Knowledge Enabled Ligand Design), August 26–30, 2012, Vienna, Austria
Volume 32, Issue 5-6, pages 555–562, June 2013
How to Cite
Tsareva, D. A. and Ecker, G. F. (2013), How Far Could We Go with Open Data – A Case Study for TRPV1 Antagonists. Mol. Inf., 32: 555–562. doi: 10.1002/minf.201300019
- Issue online: 20 JUN 2013
- Version of Record online: 18 JUN 2013
- Manuscript Accepted: 14 MAY 2013
- Manuscript Received: 11 FEB 2013
- Funded Access
- Innovative Medicines Initiative Joint Undertaking. Grant Number: n°115191
- European Union’s Seventh Framework Program. Grant Number: FP7/2007–2013
- EEPIA companies’
- FWF doctoral program. Grant Number: n°W1232
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.